November 26, 2024
TOPLINE: Use of the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and liraglutide is linked to a lower risk for alcohol use disorder (AUD)–related hospitalizations compared […]
November 26, 2024
Less than a decade ago, the use of wearable devices in Parkinson’s disease (PD) was considered futuristic. Today, there’s an array of innovative tools from commercial […]
November 26, 2024
TOPLINE: Global antipsychotic polypharmacy use increased significantly from 1970 to 2023, with 25% of antipsychotic users receiving multiple prescriptions, new research shows. Antipsychotic polypharmacy was associated […]
November 26, 2024
VANCOUVER, British Columbia — Many women who request a medical abortion at family medicine teaching clinics don’t get one, according to a survey of academic family […]
November 26, 2024
TOPLINE: A new study suggests that age is an independent risk factor for late distant recurrence among younger patients with ER-positive, ERBB2-negative breast cancer. In the […]
November 26, 2024
WASHINGTON — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications appear beneficial for people with systemic lupus erythematosus (SLE) and lupus nephritis, two new studies suggest. […]
November 26, 2024
TOPLINE: Lichen planus (LP) affects an estimated 0.15% of US adults, and more than half of patients do not receive treatment within a year of diagnosis […]
November 26, 2024
Six times as many cases of pertussis were reported in the United States for the week ending November 16, 2024, as the same week in 2023, […]
November 26, 2024
(Reuters) -Amgen’s experimental drug MariTide helped overweight or obese patients lose up to 20% weight on average in a year-long mid-stage trial, data that missed lofty […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482
Next page